PHARMACY

Cardinal Health develops patient-friendly heart health education program for community pharmacists

BY Michael Johnsen

DUBLIN, Ohio — Cardinal Health on Thursday announced it is providing free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing cardiovascular disease.  “By using these patient-friendly heart health materials, community pharmacists can strengthen their relationships with patients and help save lives by educating their communities about how to prevent and recognize the symptoms of heart attacks and strokes," stated Ron Clerico, VP marketing for Cardinal Health’s Retail Pharmacy business. 

The materials include an interactive presentation which helps pharmacists educate patients about heart health, risk prevention and daily heart health management. The presentation also focuses on how patients can build their relationships with their local pharmacist to improve healthcare outcomes. There are also customizable posters, bag clippers and flyers to drive traffic to heart health educational sessions, patient informational handouts and recipe cards for heart-healthy meals.

Cardinal Health also offers a Specialized Care Center focused on heart health. “With our Heart Health Specialized Care Center, pharmacists can take an active role in improving healthcare outcomes for patients who are at risk of contracting cardiovascular disease,” Clerico said. “This unique combination of training, education, tools and support empowers pharmacists to position themselves as their community’s local destination – and trusted advisor – for heart health.” 


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Fred’s looking toward accelerating pharmacy growth in 2013

BY Michael Johnsen

MEMPHIS, Tenn. — Fred’s Super Dollar on Thursday reported sales for the five-weeks ended Feb. 2 were up 31% to $173.6 million. Comparable store sales were up 28.6%. 

On an adjusted basis, which eliminates the one week ended Feb. 2, sales were up 2% and same-store sales were flat, Fred’s added. 

"This improvement reflected the initiatives we have put in place in tobacco, programs to drive higher ticket amounts, and continued increases in pharmacy script growth," reported Bruce Efird, Fred’s CEO. "We look forward to the new year and our expansion in specialty pharmacy and clinical services, an acceleration of pharmacy acquisitions, our expansion of new auto and hardware product initiatives, and a roll out of new concepts, such as the smaller drug and dollar store," he added. "Considering Fred’s growth prospects in the rapidly changing pharmacy industry, along with our new general merchandise initiatives, we believe there are significant opportunities to drive higher sales and profits in 2013."

On an unadjusted basis, Fred’s also reported fourth quarter total sales increased 7% to $533.5 million. Comparable store sales increased 4.8%. And total sales for the 53-week fiscal 2012 increased 4% to $2 billion and full-year same-store sales were up 1.1% on an unadjusted basis. With the one week ended Feb. 2 extracted, adjusted total sales were flat for the fourth quarter and increased 2% for fiscal 2012. Comparable sales were down 2.8% for the fourth quarter and down 1.4% for the full year. 

During January, Fred’s opened two new stores, closed one store and closed one Xpress pharmacy. For the year, Fred’s added a net total of 12 new locations, consisting of 20 new stores and 6 new Xpress pharmacies, which was offset by the closing of 14 company-owned stores. The company also opened 24 new pharmacies in 2012 and closed 3, for a net addition of 21 pharmacies during the year.


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves Sandoz antibiotic

BY Alaric DeArment

PRINCETON, N.J. — The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

Sandoz, the generics arm of Swiss drug maker Novartis, announced the approval and launch of clindamycin in 5% dextrose in minibag form, the first generic version of Pfizer’s Cleocin Phosphate in Dextrose 5%.

Sales of the branded version were $52.2 million in 2012, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?